Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Intangibles (2025)

China Pharma Holdings (CPHI) has disclosed Change in Intangibles for 6 consecutive years, with $39987.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Intangibles changed N/A year-over-year to $39987.0, compared with a TTM value of -$1.6 million through Sep 2025, changed N/A, and an annual FY2024 reading of $253307.0, changed N/A over the prior year.
  • Change in Intangibles was $39987.0 for Q3 2025 at China Pharma Holdings, up from $9986.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $39987.0 in Q3 2025 and bottomed at $9986.0 in Q2 2025.